Stable Istotope Labelled Vesencumab Biosimilar – Anti-Neuropilin-1/NRP1/VEGF165R extracellular domain mAb – Research Grade
Size | |
---|---|
Brand | |
Product type | |
Clonality | |
Expression system | |
Applications |
Product name | Stable Istotope Labelled Vesencumab Biosimilar - Anti-Neuropilin-1/NRP1/VEGF165R extracellular domain mAb - Research Grade |
---|---|
Source | CAS 1205533-60-3 |
Species | Homo sapiens |
Expression system | Mammalian cells |
Purity | >95% |
Buffer | PBS buffer PH7.5 |
Delivery condition | Blue Ice |
Delivery Time | 3-5 days if in stock; 5-8 weeks if production needed |
Storage condition | store at -80°C |
Brand | ProteoGenix |
Aliases /Synonyms | MNRP1685A |
Reference | PX-TA1266-SIL |
Note | For research use only. Not suitable for clinical or therapeutic use. |
Isotype | IgG1-kappa |
Clonality | Monoclonal Antibody |
Format | Lyophilized |
Labelling | Arginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99% |
Isotopic Enrichment | 99% |
Stability | 1 year |
General information on Anti-Neuropilin-1/NRP1/VEGF165R extracellular domain [Homo sapiens] (Vesencumab) Monoclonal Antibody
Vesencumab is investigated for the treatment of Locally Advanced or Metastatic Solid Tumors.
Contact us
Send us a message from the form below
Reviews
There are no reviews yet.